Recent advances and opportunities in research on Lupus: Environmental influences and mechanisms of disease

Environmental Health Perspectives

Volumn 116, Issue 6, 2008, Pages 695-702

  Cooper, Glinda S ^a   Gilbert, Kathleen M ^b   Greidinger, Eric L ^c   James, Judith A ^d   Pfau, Jean C ^e   Reinlib, Leslie ^f   Richardson, Bruce C ^g   Rose, Noel R ^h  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF MONTANA   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant effect; Apoptosis; Autoimmune diseases; Bystander effect; Demethylation; Epigenetics; Epstein Barr virus; Silica; Systemic lupus erythematosus; Trichloroethylene

Indexed keywords

AUTOANTIGEN; DNA; SILICON DIOXIDE; TOLL LIKE RECEPTOR; TRICHLOROETHYLENE;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BYSTANDER EFFECT; DISEASE MODEL; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; EPSTEIN BARR VIRUS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, BIOLOGICAL; PARTICULATE MATTER; VIRUS DISEASES;

HUMAN HERPESVIRUS 4; MUS;

EID: 44949088275     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11092     Document Type: Review

References (107)

1. Andrade F, Casciola-Rosen LA, Rosen A. 2005. Generation of novel covalent RNA-protein complexes in cells by ultraviolet B irradiation: implications for autoimmunity. Arthritis Rheum 52:1160-1170.
2. Arbuckle MR, Reichlin M, Harley JB, James JA. 1999. The development of lupus humoral autoimmunity for anti-Sm autoantibodies is consistent with predictable sequential B cell epitope spreading. Scand J Immunol 50:447-455.
3. Ballestar E, Esteller M, Richardson BC. 2006. The epigenetic face of systemic lupus erythematosus. J Immunol 176:7143-7147.
4. Barbarin V, Nihoul A, Misson P, Arras M, Delos M, Leclercq I, et al. 2005. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res 6:112.
5. Beamer CA, Holian A. 2007. Antigen presenting cell population dynamics during routine silicosis. Am J Respir Cell Mol Biol 37:729-738.
6. Blossom SJ, Doss JC, Gilbert KM. 2007. Chronic exposure to a trichloroethylene metabolite in autoimmune-prone MRL+/+ mice promotes immune modulation and alopecia. Toxicol Sci 95:401-407.
7. Blossom SJ, Gilbert KM. 2006. Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding. Toxicol Sci 92:103-114.
8. Blossom SJ, Pumford NR, Gilbert KM. 2004. Activation and attenuation of apoptosis of CD4+ T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J Autoimmun 23:211-220.
9. Brown JM, Archer AJ, Pfau JC, Holian A. 2003. Silica accelerated systemic autoimmume disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 131:415-421.
10. Brown JM, Pfau JC, Holian A. 2004a. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol 16:133-139.
11. Brown JM, Pfau JC, Pershouse MA, Holian A. 2004b. Silica, apoptosis, and autoimmunity. J Immunotoxicol 1:177-187.
12. Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A, Metcalfe DD. 2007. Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol 2007 36:43-52.
13. Brown JM, Schwanke CM, Pershouse MA, Pfau JC, Holian A. 2005. Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol 289:L990-L998.
14. Carlsten C, de Roos AJ, Kaufman JD, Checkoway H, Wener M, Seixas N. 2007. Cell markers, cytokines, and immune parameters in cement mason apprentices. Arthritis Rheum 57:147-153.
15. Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, et al. 2005. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 32:44-47.
16. Chen M, Dittmann A, Kuhn A, Ruzicka T, von Mikecz A. 2005. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Arthritis Rheum 52:877-884.
17. Chen M, von Mikecz A. 2005. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma. Ann NY Acad Sci 1051:382-389.
18. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, et al. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160-1164.
19. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. 2006 Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 26:417-428.
20. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, et al. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 196:135-140.
21. Cooper GS, Miller FW, Germolec DR. 2002. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2:303-313.
22. Dalldorf G, Carvalho RP, Jamra M, Frost P, Erlich D, Marigo C. 1972. The lymphomas of Brazilian children. J Am Med Assoc 208:1365-1368.
23. Davis GS, Holmes CE, Pfeiffer LM, Hemenway DR. 2001. Lymphocytes, lymphokines, and silicosis. J Environ Pathol Toxicol Oncol 20(suppl 1):53-65.
24. Delgado L, Parra ER, Capelozzi VL. 2006. Apoptosis and extracellular matrix remodelling in human silicosis. Histopathology 49:283-289.
25. Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, et al. 2001. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 44:397-407.
26. Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, et al. 2003. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 48:746-756.
27. Drappa J, Brot N, Elkon KB. 1993. The Fas protein is expressed at high levels an CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupusprone strain, MRL lpr/lpr. Proc Natl Acad Sci USA 90:10340-10344.
28. Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku O, Steele R, Barrett M, et al. 2004. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity 37:131-145.
29. Garn H, Friedetzky A, Kirchner A, Jager R, Gemsa D. 2000. Experimental silicosis: a shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes. Am J Physiol Lung Cell Mol Physiol 278:L1221-L1230.
30. Gilbert KM, Pumford NR, Blossom SJ. 2006. Environmental contamitant trichloroethylene promotes autoimmune disease and inhibits T-cell apoptosis in MRL+/+ mice. J Immunotoxicol 3:263-267.
31. Gomez D, Correa PA, Gomez LM, Cadena J, Molina JF, Anaya JM. 2004. Th1/ Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 33:404-413.
32. Gorelik G, Fang J. Wu A, Sawalha A, Richardson B. 2007. Impaired T cell PKC delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus1. J Immunol 179:5553-5563.
33. Grader-Beck T, Casciola-Rosen L, Lang TJ, Puliaev R, Rosen A, Via CS. 2007. Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus. J Immunol 178:95-102.
34. Graham KL, Thibault DL, Steinman JB, Okeke L, Kao PN, Utz PJ. 2005. Granzyme 8 is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus. Arthritis Rheum 52:1684-1693.
35. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, et al. 2007. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Aced Sci USA 104:6758-6763.
36. Greidinger EL, Zang Y, Jaimes K, Hogenmiller S, Nassiri M, Bejarano P, et al. 2006. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 54:661-669.
37. Greidinger EL, Zang Y, Martinez L, Jaimes K, Nassiri M, Bejarano P, et al. 2007. Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs. Arthritis Rheum 56:1589-1597.
38. Griffin JM, Blossom SJ, Jackson SK, Gilbert KM, Pumford NR. 2000a. Trichloroethylene accelerates an autoimmune response in association with Th1 T cell activation in MRL+/+ mice. Immunopharmacology 46:123-137.
39. Griffin JM, Gilbert KM, Lamps LW, Pumford NR. 2000b. CD4+ T cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci 57:345-352.
40. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. 2005. EBV and systemic lupus erythematosus: a new perspective. J Immunol 174:6599-6607.
41. Halmes NC, McMillan DC, Oatis JE, Pumford NR. 1996. Immunochemical detection of protein adducts in mice treated with trichloroothylene. Chem Res Toxicol 9:451-456.
42. Hamilton RF, Iyer LL, Holian A. 1996. Asbestos induces apoptosis in human alveolar macrophages. Am J Physiol 271:L813-L819.
43. Hamilton RF Jr, Thakur SA, Mayfair JK, Holian A. 2006. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J Biol Chem 281:34218-34226.
44. Hill SL, Afanasyeva M, Rose NR. 2002. Autoimmune myocarditis. In: The Molecular Pathology of Autoimmune Diseases. 2nd ed. (Theofilopoulos A, Bona CA, eds). New York:Taylor & Francis, 951-964.
45. Hoffman RW, Gazitt T, Foecking MF, Ortmann RA, Misfeldt M, Jorgenson R, et al. 2004. U1 RNA induces innate immunity signaling. Arthritis Rheum 50:2891-2896.
46. Hu S, Zhao H, Al-Humadi NH, Yin XJ, Ma JK. 2006. Silica-induced apoptasis in alveolar macrophages: evidence of in vivo thiol depletion and the activation of mitpchondrial pathway. J Toxicol Environ Health A 69:1261-1284.
47. Huaux F. 2007. New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 7:168-173.
48. Iavicoli I, Marinaccio A, Carelli G. 2005. Effects of occupational trichloroethylene exposure on cytokine levels in workers. J Occup Environ Med 47:453-457.
49. James JA, Harley JB. 1998. B cell epitope spreading in autoimmunity. Immunol Rev 164:184-200.
50. James JA, Harley JB, Scofield RH. 2006. Epstein-Barr virus and SLE. Curr Opin Rheumatol 18:462-467.
51. James JA, Kaufman KM, Farris AD, Albert ET, Lehman TJA, Harley JR. 1997. An increased prevalence of EBV infection in young patients suggests a possible etiology for SLE. J Clin Invest 100:3019-3026.
52. Jindal SK, Agarwal R. 2005. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med 11:438-446.
53. Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, et al. 2004. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172:1287-1294.
54. Khan MF, Kaphalia BS, Prabhakar BS, Kanz MF, Ansari GA. 1995. Trichloroethylene-induced autoimmune response in female MRL+/+ mice. Toxicol Appl Pharm 134:155-160.
55. Kitagawa H, Iho S, Yokochi T, Hoshino T. 1988. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol Lett 17:249-252.
56. Kuhn A, Herrmann M, Kleber S, Beckmann-Welle M, Fehsel K, Martin-Villalba A, et al. 2006. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 54:939-950.
57. Kurosu T, Tsuji K, Kida A, Koyama T, Yamamoto M, Miura O. 2007. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta. Oncogene 26:2975-2987.
58. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. 1991. LPS promotes CB3-induced mycocarditis in resistant B10.A mice. Cell Immunol 136:219-233.
59. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. 1992. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 175:1123-1129.
60. Lee BH, Yegnasubramanian S, Lin X, Nelson WG. 2005. Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 280:40749-40756.
61. Lennette ET, Rymo L, Yadav M, Masucci G, Merk K, Timar L, et al. 1993. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1. EBNA 2 and EBNA 6. Eur J Cancer 29A:1584-1589.
62. Lipscomb JC, Mahle DA, Brashear WT, Garrett CM. 1996. A species comparison of chloral hydrate metabolism in blood and liver. Biochem Biophys Res Commun 227:340-350.
63. Lu JJ, Chen CY, Hsieh DW, Lan JL, Lin FJ, Lin SH. 2007. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 16:168-175.
64. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B. 2007. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 179:6352-6358.
65. Luzina IG, Atamas SP, Wise R, Wigley FM, Choi J, Xiao HQ, et al. 2003. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum 48:2262-2274.
66. McClain MT, Harley JB, James JA. 2001. The role of Epstein-Barr virus in systemic lupus erythematosus. Front Biosci 6:E137-E147.
67. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. 2005. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85-89.
68. McClain MT, Poole B, Bruner BF, Kaufman KM, Harley JB, James JA. 2006. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric SLE. Arthritis Rheum 54:360-368.
69. Mevorach D, Zhou JL, Song X, Elkon KB. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387-392.
70. Migliaccio CT, Hamilton RF Jr, Holian A. 2005. Increase in a distinct pulmonary macrophage subset possessing an antigen-presenting cell phenotype and in vitro APC activity following silica exposure. Toxicol Appl Pharmacol 205:168-176.
71. Misson P, van den Brule S, Barbarin V, Lison D, Huaux F. 2004. Markers of macrophage differentiation in experimental silicosis. J Leukoc Biol 76:926-932.
72. Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, et al. 2004. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr viral load in blood. Arthritis Res Ther 6:R295-R302.
73. NIAMS (National Institute of Arthritis and Musculoskeletal Diseases). 2007. The Future Directions of Lupus Research. Available: http://www.niams.nih.gov/About_Us/Mission_and_Purpose/lupus_plan.pdf [accessed 18 February 2008].
74. Ngou J, Graafland H, Segondy M. 1992. Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseases. J Autoimmun 5:243-249.
75. Nuckols JR, Ward MH, Jarup L. 2004. Using geographic information systems for exposure assessment in environmental epidemiology studies. Environ Health Perspect 112:1007-1015.
76. Otsuki T, Miura Y, Nishimura Y, Hyodoh F, Takata A, Kusaka M, et al. 2005. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol Med (Maywood) 231:522-533.
77. Parks CG, Conrad K, Cooper GS. 1999. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107(suppl 5):793-802.
78. Parks CG, Cooper GS. 2006. Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus 15:728-736.
79. Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, et al. 2005, Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148-1159.
80. Power RD, Patole PS, Ellwart A, Lech M, Segerer S, Schlondorff D, et al. 2006. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis. J Am Soc Nephrol 17:3365-3373.
81. Pernis B. 2005. Silica and the immune system. Acta Biomed 76(suppl 2):38-44.
82. Pfau JC, Brown JM, Holian A. 2004. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 195: 167-176.
83. Pisitkun P, Deane JA, Difilippantonio MJ, Terasenko T, Satterthwaite AB, Bolland S. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669-1672
84. Poole BD, James JA. 2007. Infection and autoimmunity. In: Systemic Lupus Erythematosus (Tsokos GC, Gordon C, Smolen JS, eds). Philadelphia:Elsevier Inc., 143-155.
85. Poole BD, Scofield H, Harley JB, James JA. 2006, Epstein-Barr virus and molecular mimicry in SLE. Autoimmunity 39:63-70.
86. Remmers EF, Plenge RM, Lee AT, Graham RR, Ham G, Behrens TW, et al. 2007. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977-986.
87. Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH. 1985. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J Immunol 134:211-217.
88. Richardson B. 2007. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 3:521-527.
89. Rocchi R, Hiroaki K, Tzou S, Suzuki K, Rose NR, Pinchera A, et al. 2007. Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness. Proc Natl Acad Sci USA 104:6019-6024.
90. Rose NR, Afanasyeva M. 2003. From infection to autoimmunity: the adjuvant effect. ASM News 69:132-137.
91. Rudofsky UH, Lawrence DA. 1999. Now Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect 107(suppl 5):713-721.
92. Schwartz D, Collins F. 2007. Environmental biology and human disease. Science 316:696-697.
93. Shukla A, Stern M, Lounsbury KM, Flanders T, Mossman BT. 2003. Asbestos-induced apoptosis is protein kinase C delta-dependent. Am J Respir Cell Mol Biol 29:198-205.
94. Singh RR. 2003. IL-4 and many roads to lupuslike autoimmunity. Clin Immunol 108:73-79.
95. Stranges PB, Watson J, Cooper CJ, Choisy-Rossi CM, Stonebraker AC, Beighton RA, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by fas contributes to prevention of autoimmunity. Immunity 26:629-641.
96. Thompson MP, Kurzrock R. 2004. Epstein-Barr virus and cancer. Clin Cancer Res 10:803-821.
97. Trouw LA, Blom AM, Gasque P. 2008. Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol 45:1199-1207.
98. Venkatesh J, Peeva E, Xu X, Diamond B. 2006. Cutting edge: hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J Immunol 176:3311-3314.
99. Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, et al. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves toll-like receptors 7 and 8. J Exp Med 202:1575-1585.
100. Walport MJ. 2000. Lupus, DNase and defective disposal of cellular debris. Nat Genet 25:135-136.
101. Wang G, Cai P, Ansari GA, Khan MF. 2007. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 229:186-193.
102. Waterland RA, Jirtle RL. 2004. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility ito adult chronic diseases. Nutrition 20:63-68.
103. Wu P, Miura Y, Hyodoh F, Nishimura Y, Hatayama T, Hatada S, et al. 2006. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol 19:357-368.
104. Xu L, Zhang L, Yi Y, Kong HK, Datta SK. 2004. Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med 10:411-415.
105. Yu SF, Wu HC, Tsai WC, Yen JH, Chiang W, Yuo CY, et al. 2005. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus. Med Microbiol Immunol 194:115-120.
106. Yung R, Kaplan M, Ray D, Schneider K, Mo RR, Johnson K, Richardson B. 2001. Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies. Lupus 10:539-546.
107. Zoller M, McElwee KJ, Vitacolonna M, Hoffmann RR. 2004. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients. J Autoimmun 23:241-256.